SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-009927
Filing Date
2020-04-23
Accepted
2020-04-23 16:03:58
Documents
6
Period of Report
2020-06-09
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0420_artara.htm DEF 14A 1171594
2 GRAPHIC artaralogo.jpg GRAPHIC 107018
3 GRAPHIC artaralogo1.jpg GRAPHIC 107007
4 GRAPHIC proxy_001.jpg GRAPHIC 1079113
5 GRAPHIC proxy_002.jpg GRAPHIC 716868
6 GRAPHIC sign_001.jpg GRAPHIC 28088
  Complete submission text file 0001213900-20-009927.txt   3941771
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36694 | Film No.: 20811034
SIC: 2836 Biological Products, (No Diagnostic Substances)